Thirona
- Company typePrivate
- Founded2014
- HeadquartersNijmegen, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Thirona firmographics
Firmographics- Name
- Thirona
- Legal name
- Thirona B.V.
- Website
- https://thirona.eu
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Thirona industry classification
Industry- Product category
- Medical Imaging AI Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI), Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI)
Keywords
Where Thirona is headquartered
LocationHeadquarters
- HQ city
- Nijmegen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Thirona business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Drug Development Services: Quantitative CT analysis and treatment efficacy assessment for imaging-based respiratory clinical trials serving pharmaceutical companies developing novel therapies.
- Pulmonary Interventions Technology: AI-enabled imaging technology licensing for next-generation bronchoscopic and surgical procedures serving MedTech companies.
- LungQ Software Platform: AI-powered lung image analysis software offered as clinical software with regulatory clearance (FDA 510(k), CE certified) for clinical use and clinical research.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Thirona product offering
Product offeringCore offering
Thirona develops and sells AI-powered software for quantitative analysis of lung CT images, centered on its modular LungQ platform that performs advanced anatomical segmentation, disease quantification, and bronchoscopy pathway planning. The software supports pharmaceutical companies running imaging-based respiratory clinical trials, MedTech firms developing pulmonary interventions, and hospitals delivering clinical care for COPD, cystic fibrosis, severe asthma, bronchiectasis, and pulmonary hypertension.
Product overview
Thirona offers a modular AI-powered product portfolio centered on its LungQ® platform for thoracic medical image analysis. LungQ® is a comprehensive technology portfolio of advanced deep-learning algorithms providing market-unique segmentation and quantification capabilities for chest CT scans. The platform is built as a modular architecture with specialized analysis modules including LungQ® BA (Bronchus-Artery Analysis), LungQ® VERA (Ventilation Estimation), LungQ® AVX (Artery Vein Phenotyping), LungQ® PXT (Perfusion Defect), LungQ® MP (Mucus Plugs Analysis), and LungQ® Navia (Bronchoscopy Pathway Planning). Thirona also offers CAD4COVID-CT and CAD4COVID-XRay for COVID-19 analysis, and previously offered CAD4TB for tuberculosis screening and RetCAD™ for retinal analysis (spun off in 2024). The products support pharmaceutical drug development, pulmonary interventions, and clinical care across therapeutic areas including COPD, bronchiectasis, severe asthma, cystic fibrosis, and pulmonary hypertension.
Differentiator
Problem solved
Functional benefit
Brands
- LungQ: AI-powered lung image analysis platform offering advanced segmentation and quantification capabilities for thoracic CT scan analysis, supporting drug development and pulmonary interventions
- RetCAD
- CAD4COVID
- CAD4TB
Products and services
- LungQ Modular AI-powered software platform for thoracic CT image analysis that delivers advanced deep-learning segmentation and quantification of lung anatomy and diseased lung regions for pharmaceutical drug development, MedTech intervention planning, and clinical care.
- CAD4COVID-CT AI software for automated analysis of COVID-19 on CT scans, providing standardized measurement of pulmonary involvement and severity assessment based on percentage of affected lung area; CE certified and FDA authorized.
- CAD4COVID-XRay AI tool for triaging suspected COVID-19 cases by analyzing chest X-rays, CE certified, and performing comparably to radiologists in triaging suspected COVID-19 cases.
- CAD4TB AI-based tuberculosis detection solution for chest X-ray analysis, used to screen large populations for tuberculosis across multiple countries.
Quantifiable outcome
- AI-enabled analysis detects subtle structural changes in airways that visual reads cannot identify
- +3 more outcomes
Companies that use Thirona
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Thirona technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature8 records
Thirona partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- BlackfordcoreCommercial partnership to bring LungQ solution to healthcare professionals via the Blackford Platform, expanding distribution reach.
- VoiantcoreGlobal commercial partnership for full scope integral services for clinical trials with AI-powered lung image analysis, building on several years of fruitful cooperation.
- AidenceminorJoint clinical solution with Aidence and Incepto to support expansion of lung cancer screening in Europe with AI-powered software package.
- InceptominorJoint clinical solution with Aidence and Thirona for lung cancer screening and emphysema analysis, bringing AI into hospitals through integration partnerships.
- MedicalVRminorCollaboration to integrate Thirona's chest CT analysis software into the PulmoVR virtual reality application for pre-operative planning of segmentectomy.
- Erasmus Medical CentercorePilot study collaboration with Cardio-thoracic Surgery department using virtual reality for complex lung surgery preparation, demonstrating 40% change in surgical strategy after VR review.
- COPDGene StudycoreResearch partner for imaging arm of the study providing AI-based quantitative CT scan analysis (emphysema quantification, airway measurements) for over 10,000 participants.
- OSIC (Open Source Imaging Consortium)coreGlobal consortium bringing together radiologists, clinicians, computational scientists, and industry leaders to develop respiratory digital imaging biomarkers using the world's largest clinical imaging database.
- European Bronchiectasis Registry (EMBARC)coreCollaborative European research partnership applying AI-powered lung image analysis to enable deeper insights and comprehensive understanding of bronchiectasis disease mechanisms, analyzing over 600 CT scans.
- European Cystic Fibrosis Society Patient Registry / ENRICH ProjectcoreEuropean initiative to standardize QCT metrics in CF population data, analyzing up to 10,000 CT scans from over 3,000 patients across 12 countries and 20 CF centers.
- CHU LiègeminorResearch collaboration using LungQ AVX for artery-vein phenotyping in studies of pulmonary vascular diseases and pulmonary hypertension with Prof. Julien Guiot's team.
- CHU MontpellierminorResearch collaboration using AI-driven quantitative CT analysis for studying biologic treatment effects in severe asthma patients with Prof. Arnaud Bourdin's team.
- DRAGON Project ConsortiumminorPublic-private consortium investigating risk factors for developing lung damage and chronic complaints after COVID-19, developing decision support system for precise COVID-19 diagnosis using CT scanning.
- RetCAD Business Spin-outminorThirona spun out its Retina business as of January 1st to pursue long-term growth plans for the RetCAD product line.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Thirona competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers (AI-Rad Companion): Siemens Healthineers' AI-Rad Companion offers AI-driven chest CT analysis embedded in the broader Siemens imaging ecosystem. It is a broad incumbent competitor with deep hospital integration and CT scanner footprint.
- Philips (IntelliSpace AI): Philips offers enterprise imaging AI through IntelliSpace AI and is also a Thirona integration partner. As a broad incumbent, it competes and partners simultaneously with Thirona in the lung imaging space.
- Aidoc: Aidoc is a leading AI imaging vendor offering a broad suite of triage and workflow algorithms across multiple modalities, including chest. It overlaps with Thirona on chest CT and operates as a broader, well-funded incumbent.
Direct peers
- icometrix: icometrix provides quantitative imaging AI biomarkers for clinical care and clinical trials; while focused on neuroimaging, it competes for pharma quantitative-imaging-endpoint budgets and uses similar regulatory and distribution models.
- Quibim: Quibim provides AI-based medical image analysis with a focus on oncology and quantitative imaging biomarkers. It competes with Thirona for pharma/CRO quantitative imaging endpoints in clinical trials.
- Annalise.ai: Annalise.ai offers comprehensive radiology AI including chest CT/X-ray modules covering pulmonary findings. It is a direct competitor in AI chest imaging for clinical reporting and triage.
- Aidence: Aidence is a European AI medical imaging company focused on lung cancer screening and pulmonary nodule detection on chest CT. It directly overlaps with Thirona's LungQ on lung CT analysis and is even a co-development partner on a joint lung-cancer screening solution with Incepto.
- Arterys: Arterys offers cloud-native AI imaging platforms including chest and cardiac analysis, and competes in the enterprise imaging AI space with Thirona for hospital and clinical-trial deployments.
- Riverain Technologies: Riverain Technologies (ClearRead) provides AI-driven chest CT and X-ray analysis for lung nodule detection and thoracic imaging workflow. It competes head-to-head with Thirona in AI lung image analysis for hospitals and clinical use.
Others
- Incepto: Incepto is a European AI imaging platform/distributor that aggregates third-party algorithms (including Thirona's via a joint lung-cancer screening offering). It is an adjacent channel/distribution player rather than a direct technology competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Thirona social profiles
Digital presenceThirona compliance and trust
Trust signalCompliance7 records
Thirona financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thirona leadership team
Management profileNumber of profiles
Profiles5 records
Thirona subsidiaries and ownership
Company hierarchySubsidiaries1 record
Thirona funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thirona M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thirona
What does Thirona do?
Thirona develops and sells AI-powered software for quantitative analysis of lung CT images, centered on its modular LungQ platform that performs advanced anatomical segmentation, disease quantification, and bronchoscopy pathway planning. The software supports pharmaceutical companies running imaging-based respiratory clinical trials, MedTech firms developing pulmonary interventions, and hospitals delivering clinical care for COPD, cystic fibrosis, severe asthma, bronchiectasis, and pulmonary hypertension.
Is Thirona a public or private company?
Thirona is a private company. It is classified as venture growth investor backed and is currently operating.
When was Thirona founded?
Thirona was founded in 2014. It employs 11 to 50 people.
Where is Thirona based?
Thirona is headquartered in Nijmegen, Netherlands, in the Europe region.
How does Thirona make money?
Three revenue lines are on record. Pharmaceutical Drug Development Services are the primary driver. The others are pulmonary Interventions Technology and lungQ Software Platform.
Who are Thirona's main competitors?
Broad incumbents on record are Siemens Healthineers (AI-Rad Companion), Philips (IntelliSpace AI) and Aidoc. Direct peers are icometrix, Quibim, Annalise.ai, Aidence, Arterys and Riverain Technologies. Incepto is listed as an others.
Does Thirona have an API?
No public API is recorded for Thirona.
What industry is Thirona in?
Thirona's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 7372.